Emtux 100 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Emtux 100 mg Injection

Emtux 100 mg Injection

Emtux 100 mg Injection contains rituximab and is a monoclonal antibody medicine used for certain blood cancers and autoimmune conditions. It targets the CD20 protein on B cells and helps the immune system remove abnormal cells. The medicine is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to CD20-positive B cells and promotes their destruction through immune-mediated mechanisms. Emtux 100 mg Injection may be used in treatment regimens for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and selected autoimmune diseases. The medicine is given according to a prescribed dosing schedule and requires appropriate preparation and controlled intravenous administration. Patients are generally monitored for infusion-related reactions, infections, blood count changes, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Dosage Form Injection
Concentration 10 mg/mL
Fill Volume 10 mL
Route of Administration Intravenous infusion

Product Also Known As

Emtux 100 mg, Emtux 100 mg Injection, Emtux 100 mg/10 mL, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL, Rituximab Injection, Anti-CD20 Monoclonal Antibody